Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-22 Sale | 2024-07-23 4:37 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,000 | $53.93 | $269,662 | 15,480 (Direct) | View |
| 2024-06-26 Sale | 2024-06-28 4:06 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 30,000 | $51.93 | $1,557,940 | 60,480 (Direct) | View |
| 2023-02-16 Sale | 2023-02-21 7:00 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2,525 | $49.26 | $124,382 | 106,722 (Direct) | View |
| 2022-11-15 Sale | 2022-11-16 7:51 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,000 | $53.81 | $269,053 | 4,045 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-22 Exercise | 2024-07-23 4:37 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,000 | $22.5 | 15,480 (Direct) | View |
| 2024-07-22 Exercise | 2024-07-23 4:37 pm | N/A 2025-07-01 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,000 | $0 | 15,480 (Direct) | View |
| 2024-06-26 Exercise | 2024-06-28 4:06 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 30,000 | $22.5 | 60,480 (Direct) | View |
| 2024-06-26 Exercise | 2024-06-28 4:06 pm | N/A 2025-07-01 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 30,000 | $0 | 60,480 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 5:05 pm | 2025-02-23 2034-02-23 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 54,473 | $0 | 54,473 (Direct) | View |
| 2024-02-16 Tax Withholding | 2024-02-20 6:53 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,601 | $36.1 | 41,653 (Direct) | View |
| 2024-02-16 Exercise | 2024-02-20 6:53 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 10,422 | $0 | 41,653 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-16 5:41 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 686 | $35.91 | 11,913 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 5:41 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 1,254 | $0 | 11,913 (Direct) | View |
| 2024-02-10 Exercise | 2024-02-13 4:15 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2,502 | $0 | 10,091 (Direct) | View |
| 2024-02-10 Tax Withholding | 2024-02-13 4:15 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 1,477 | $35.49 | 10,091 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 7:00 pm | 2024-02-16 2033-02-16 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 82,377 | $0 | 106,722 (Direct) | View |
| 2023-02-16 Exercise | 2023-02-21 7:00 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,094 | $0 | 106,722 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 06:25 am | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 621 | $49.2 | 9,005 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 06:25 am | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 1,254 | $0 | 9,005 (Direct) | View |
| 2023-02-10 Tax Withholding | 2023-02-14 5:21 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 2,073 | $48.92 | 8,366 (Direct) | View |
| 2023-02-10 Exercise | 2023-02-14 5:21 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 3,892 | $0 | 8,366 (Direct) | View |
| 2022-02-16 Option Award | 2022-02-17 6:03 pm | 2023-02-16 2032-02-16 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer | 82,688 | $0 | 95,495 (Direct) | View |
| 2022-02-15 Exercise | 2022-02-17 6:03 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer | 1,255 | $0 | 95,495 (Direct) | View |
| 2022-02-15 Tax Withholding | 2022-02-17 6:03 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer | 433 | $34.43 | 95,495 (Direct) | View |
| 2022-02-12 Tax Withholding | 2022-02-14 7:28 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer | 506 | $34.2 | 14,617 (Direct) | View |
| 2022-02-10 Tax Withholding | 2022-02-14 7:28 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer | 1,025 | $34.94 | 14,617 (Direct) | View |
| 2022-02-14 Tax Withholding | 2022-02-14 7:28 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer | 427 | $33.64 | 14,617 (Direct) | View |
| 2022-02-10 Exercise | 2022-02-14 7:28 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer | 5,148 | $0 | 14,617 (Direct) | View |
Ownership | 2022-02-11 4:21 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, Chief Financial Officer | 0 | $0 | 123,456 (Direct) | View |